(Q42752650)
Statements
1 reference
Ezetimibe, and the combination of ezetimibe/simvastatin, and risk of cancer: A post-marketing analysis (English)
1 reference
Richard H Karas
1 reference
Alawi A Alsheikh-Ali
1 reference
11 February 2009
1 reference
1 reference
3
1 reference
2
1 reference
138-142
1 reference
Identifiers
1 reference
1 reference